Disease-modifying therapies requiring frequent, self-administered injections can be particularly troublesome for some patients, as they may result in localized skin reactions at the
injection site. A variety of
injection-site reactions (ISRs) have been reported, including pain and erythema, lipoatrophy, abscesses and infections, necrosis, rash, swelling, and lumps.